Recent News

In The Press

May 22, 2019

Geller Biopharm Client, EpiBone, Inc. Receives FDA Clearance to Commence its First-In-Human, Phase 1/2 Trial of its Bone Product, EB-CMF

Download our presentation
PDF

Get a digital copy of our PDF presentation

Download PDF